9.2 C
London
Friday, December 3, 2021

Covid-19 vaccine from Pfizer / BioNTech for children 5-11 years old? The European Medicines Agency has started the evaluation

Must read

- Advertisement -


The Pfizer / BioNTech vaccine against COVID-19 is being evaluated by the European Medicines Agency in order to issue a decision approving it for children aged 5-11, the EMA said in a press release.

The European Medicines Agency (EMA) started on Monday the process of evaluating the use of the Covid-19 vaccine from BioNTech and Pfizer in children aged 5 to 11 years.

“The Committee for Medicines for Human (CHMP) EMA will review the data on the vaccine, including the results of an ongoing clinical trial in children aged 5-11 years, with a view to deciding whether to recommend extending the use of the vaccine. The CHMP opinion will then be forwarded to The European Commission, which will issue the final decision, “we read in the release sent by EMA to media representatives.

The evaluation is expected to be completed “in a few months unless additional information is required”.

Main photo source: DANIEL POCKETT / EPA / PAP

- Advertisement -



Source link

More articles

- Advertisement -

Latest article